@Doblerin "Additionally, a key domain in the spike protein of β-coronaviridae, a genus which includes SARS-CoV2, is nearly identical in morphology to human Gal-3." https://t.co/F0ZXYA64ew
@YoDoctorYo big news! The galectin-3 inhibitor TD139, a drug mentioned in the U of Illinois article, has begun clinical trials for COVID-19 treatment in the UK.
https://t.co/066AsBlvKI
https://t.co/cYJeusuoWh
@nresearchnews @Kannan9900 @CommsBio Here is another connection between #ProstateCancer and #COVID19:
Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunities
https://t.co/LucVCxP0gd
A potential role for Galectin-3 inhibitors in the treatment of COVID-19
https://t.co/pljG9Q2luV
UICOMP researchers were published in PeerJ this week. See what they have to say about an investigational cancer drug and COVID-19 -- https://t.co/KGOK8kMSfD https://t.co/hNTpkB1SV5
Article “Galectin-3 inhbitors in COVID-19” outlines the potential anti fibrotic Gal-3 inhibitor GR-MD-02 BelaPectin may have w/ #COVID
Need trials ASAP!
@GalectinGALT @SteveFDA @NIH #Covid_19 #ARDS #CytokineStorm @ArdsGlobal
https://t.co/RvPqGoYdcS via @thePeerJ
Just published in #PeerJ - A potential role for Galectin-3 inhibitors in the treatment of COVID-19 https://t.co/rFhcki5OU7
#cellbiology #molecularbiology #COVID19 https://t.co/jYuWqFKCPM